Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Iqe Plc | LSE:IQE | London | Ordinary Share | GB0009619924 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 10.54 | 413,177 | 09:20:17 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 10.42 | 10.78 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electronic Components, Nec | 115.25M | -29.38M | -0.0304 | -3.47 | 101.91M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 10:03:09 | O | 432 | 10.50 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/11/2024 | 12:23 | ALNC |  IQE eyes yearly profit climb as starts strategic review |
| 18/11/2024 | 07:00 | UK RNS | IQE PLC IQE plc: Trading Update |
| 15/11/2024 | 07:00 | UK RNS | IQE PLC Holding(s) in Company |
| 14/11/2024 | 07:00 | UK RNS | IQE PLC IQE plc: Holding(s) in Company |
| 31/10/2024 | 07:00 | UK RNS | IQE PLC IQE plc: Total Voting Rights |
| 29/10/2024 | 12:38 | ALNC | EXECUTIVE CHANGES: IQE chair-elect takes over as CEO exits immediately |
| 29/10/2024 | 07:00 | UK RNS | IQE PLC IQE plc: IQE announces departure of CEO |
| 14/10/2024 | 15:00 | UK RNS | IQE PLC IQE plc: Holding(s) in Company |
| 08/10/2024 | 06:00 | UK RNS | IQE PLC IQE plc: Appointment of NED and Chair-elect |
| 30/9/2024 | 15:00 | UK RNS | IQE PLC IQE plc: Total Voting Rights |
Iqe (IQE) Share Charts1 Year Iqe Chart |
|
1 Month Iqe Chart |
Intraday Iqe Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 20/11/2024 | 20:25 | New CEO, new hope, new start for IQE in 2022 | 5,686 |
| 18/11/2024 | 11:03 | IQE - Autonomous Vehicle Growth Play | 4 |
| 26/6/2024 | 11:13 | IQE's time has come - 2017 and beyond! | 36,725 |
| 04/1/2023 | 11:05 | IQE - THE ONLY WAY IS UP!!. | 64 |
| 17/10/2022 | 06:50 | IQE - Time to get back in after results? | 27 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 10:03:10 | 10.50 | 432 | 45.36 | O |
| 10:02:15 | 10.50 | 8 | 0.84 | O |
| 10:02:04 | 10.50 | 141 | 14.81 | O |
| 10:00:34 | 10.70 | 10 | 1.07 | O |
| 09:52:47 | 10.50 | 154 | 16.17 | O |
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by Iqe Daily Update Iqe Plc is listed in the Electronic Components, Nec sector of the London Stock Exchange with ticker IQE. The last closing price for Iqe was 10.54p.Iqe currently has 966,903,744 shares in issue. The market capitalisation of Iqe is £101,911,655. Iqe has a price to earnings ratio (PE ratio) of -3.47. This morning IQE shares opened at - |
Posted at 19/11/2024 09:28 by longtallsally Looking forward I think as always with IQE the issue will be the timing of when to bank the inevitable next share price rise. A look at the chart and history tells us it is littered with huge rise and falls over the past 20 years after times of hope and the next disappointment. Unless IQE look like they will have to be fire sold next year the share price will recover, to some degree it always does, but perhaps with just lower highs (80p won’t be seen for many years again imo)If the Taiwan IPO is successfully handled and IQE don’t issue another profit warning on next years now reduced earnings then expect the share price to be in the 20s or 30s before this time next year. The problem for investors will be as happened this year people will get carried away yet again (see Crosswires end of year share price predictions list), BUT unless there is concrete proof of big new orders we would all be best ignoring anyone predicting huge revenue increases without such proof as it often comes to nothing (see Americo Lemos or Captain Calamity as he is now known). Personally if the share price does recover well into the 30s then I will be selling and not looking back. Holding IQE has been far too stressful and disappointing and if break even could be achieved then I would be satisfied to have just lost time but not money with my investment here. |
Posted at 18/11/2024 07:18 by a13878713 Cardiff, UK18 November 2024This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). Trading Update, Strategic Review and Proposed Financing IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, provides a trading update for the year ending 31 December 2024.Revenue for the Full Year 2024 is expected to be broadly flat year-on-year, resulting in around £115m. In line with the rest of the industry, we are continuing to see a slower than anticipated recovery in key sectors driven by weak consumer demand in end markets. The group expects this to result in an Adjusted EBITDA of at least £5m.Strategic ReviewThe Board remains confident in IQE's long-term prospects because of the Group's leading position in providing advanced compound semiconductors across several market verticals and to a base of global marque customers. The Board believes there is significant value in IQE that is not currently reflected in its market capitalisation. Consequently, IQE announces today that it will be conducting a comprehensive strategic review of its asset base to ensure that it has a strong capital position to further invest in its core operations (the "Strategic Review"). The Board believes there is a significant market opportunity in IQE's core operations and remains focused on reducing its cost structure for profitable growth, servicing its customers and maximising value for shareholders.In the first instance, IQE will broaden its options in relation to the proposed IPO of its Taiwan operations to include all strategic options, including a full sale. The Board has retained Lazard to advise on the Strategic Review. The Strategic Review will be overseen by IQE's Board of Directors, with input from key stakeholders.Propose |
Posted at 13/11/2024 15:58 by dpmcq It is usually normal when a Companies share price has take a large percentage move to get the obligatory RNS -The company notes the recent share price movement and is not aware of any material reason....... If this really is the case then the board should do it sooner rather than later as the seller or sellers exiting at any cost and the lack of any real buyers, is causing a viscous circle that has destroyed the share price and the companies market capital price along with it. If this is not forthcoming I really expect the next RNS to be not pleasant. To sack a CEO with ii on the board for me is very telling. |
Posted at 13/11/2024 14:13 by crosswires James IQE still had £23m left to use on the revolving credit facility in April, and only need to get through to H2 next year for the Taiwan IPO. I don’t believe that’s an issue as either bank or large institutional investors (via another raise) would intervene before that as it’s in their interest. Share price on the back of even a modestly successful IPO next year will obviously value IQE significantly higher than here.Fear is a powerful driver of share prices on the way down just as over exuberance can be on the way up. I don’t believe we will ever know why Americo left, these things stay private on matter of principle and legality. LTS, I haven’t filtered anyone for a while so must have filtered whoever you refer to a while ago. People will believe whatever they want to, of zero interest to me either way, and yes over £200k down on paper but I feel the end game will be different. As I have said before if I lose it all it will be frustrating and obviously isn’t ideal but fortunately it won’t impact my life. |
Posted at 12/11/2024 11:04 by lammergeier We are 13 years down the road from when Intel were mooted to have offered £500 millionfor Iqe,since then a lot of money has been spent on building up the business.The intrinsic value of the Company must be a lot higher than the current Share Price. Sadly,the majority of our shareholders seem to be made up of Brokers and hedge funds which makes us a highly speculative volatile investor play.The share price drop from 35p to 11p would normally suggest we are making huge losses and in dire straits but according to the last Company release this is not the case IQE is a sittng duck for any Corporate predator whether it be friend or foe.A speculative sale of the Pensylvanian and or Taiwan operation might be the catalyst to turn things around. |
Posted at 05/11/2024 12:35 by provonar Taking a look at the CHIPS act funding process a bit further:It's clear that acquiring state/local funding is a requirement before any CHIPS act (federal) funding is confirmed. Therefore, this $2M grant from Greensboro is one of the initial steps that IQE have to go through in order to secure CHIPS act funding (and is also why the local county/state is happy to put up the money - it gets more than matched by the federal level grant). That'll also be why there's the 'no commitment' statement from IQE in that I expect both grants rely on each other - IQE won't commit anything until the entire financial construction is confirmed. What's also clear is that there needs to be significant private investment coming in to kick-start the project the CHIPS act funding is for, which is reimbursed later. So that's probably where the Taiwan IPO comes into play - raising funds to start the NC expansion that then secures CHIPS funding. There could possibly be a further funding round depending on what is needed to secure the CHIPS funding. The CHIPS grant pay-outs will be awarded when milestones are met - I doubt we'll know what those milestones are in advance (employing a certain number of new personnel; installing so many tools etc.). The federal govt. may enter a profit-sharing deal for grants over $150M, which could affect this $305M target deal that IQE appear to be going for. Of course, you have to make profits to share any, which would be nice... There'll be further things that IQE can do - $305M buys a lot of epitaxy tools. All the ones purchased under CHIPS funding will certainly have to be placed in the US (Greensboro) - however, older tools at the NC site could be moved to other sites (i.e. Wales) in order to spread capacity. With the relatively recent purchase of three tools from Aixtron for GaN epitaxy, the fact that these went to both sites in the US and UK mean that GaN capacity expansion could spread across both sites (with the most up-to-date and majority of the capacity being in the US). All quite positive (for once), but definitely shouldn't count any chickens yet - which may be why the share price hasn't responded significantly so far (I'm sure this is all pretty old news to the funds - it may even explain why there was the rise earlier in the year off not a lot of news, the recent drop being possibly due to delayed plans - exacerbated now by the CEO leaving). Now, it could become even more interesting if IQE have plans to secure the equivalent Taiwanese version of the CHIPS act funding... DYOR |
Posted at 31/10/2024 16:38 by longtallsally I think until the dust settles the only thing that will cause a meaningful spike up in the share price is an RNS that says IQE will still hit lower end of estimates this year (£130m). It may be that doesn’t come until a December TU but if the revenue is coming much lower which would cause a big fund raise then I guess a lower share price is possible as hard as that is to compute given we were at mid 30s not long ago.Given where the share price is I would think IQE would issue something that calms investors and a lack of anything is possibly counter productive if £130m will be hit this year. |
Posted at 30/10/2024 08:39 by longtallsally I think it’s easy to become paranoid about shorters, I agree their whole MO is opportunistic and counterproductive but I see no evidence and it’s not helpful to see all issues as shorter based. It seems a thing that certain investors just come out with to hide others issues.IQE have brought this share price fall onto themselves and you could argue the share price didn’t overreact yesterday, clearly large holders have been clearing for some time which has more to do with todays share price than anything else. As Guildedge says, we should find out via an RNS soon who has been bailing. Let’s hope 11p is/was the all time low. |
Posted at 25/10/2024 19:19 by 46maxon IQE is a UK-based semiconductor company that specializes in producing advanced semiconductor materials, primarily for use in technologies like smartphones, telecommunications, and, increasingly, in high-growth areas such as 5G infrastructure and electric vehicles (EVs). Here’s what to consider about IQE as a potential investment:1. Core Business and Market Position • Compound Semiconductors: IQE’s focus on compound semiconductors differentiates it from traditional silicon-based players. Compound semiconductors are vital for high-performance applications, such as photonics (sensors, facial recognition) and power electronics (5G, EVs). As these markets grow, IQE is well-positioned to benefit. • Competitive Position: IQE has strategic partnerships and a strong market position within this niche, though it faces competition from larger semiconductor manufacturers and potential advances in alternative technologies. Evaluating its ability to maintain a technological edge is key. 2. Revenue Volatility and Profitability • Cyclical Revenue: IQE’s revenue can be volatile, partly due to the cyclical nature of the semiconductor industry. Factors such as global semiconductor demand, supply chain constraints, and shifts in smartphone sales influence IQE’s performance significantly. • Profitability: Historically, IQE has faced challenges with consistent profitability, as R&D investments and production costs have impacted margins. If they’re showing signs of improving margins or increased operational efficiency, this would be a positive indicator. 3. Growth Potential in Emerging Technologies • 5G, IoT, and EVs: IQE’s products are aligned with sectors expected to grow rapidly. For example, 5G infrastructure and IoT devices require high-performance semiconductors, where IQE has a role to play. Growth in these areas could directly translate into higher revenues. • Photonic Technologies: IQE also supplies materials for photonic devices, such as lasers and sensors, used in facial recognition, autonomous driving, and other applications. If demand for these technologies grows, IQE may see a positive revenue impact. 4. Financial Health and Valuation • Balance Sheet and Debt: IQE’s debt levels and cash flow are important to examine, particularly given the high costs of R&D and manufacturing in semiconductors. Excessive debt could be a red flag, while a strong balance sheet would provide stability. • Valuation: If IQE is trading at a low valuation relative to its earnings potential and the semiconductor sector, it could be undervalued. Look at metrics like the P/E ratio, price-to-sales ratio, and compare with peers. 5. Risks and Considerations • Reliance on Key Customers: IQE may rely on a small number of large customers, which can add risk if any of these clients reduce their orders. • Technological Risks: Semiconductor technology evolves rapidly. If new materials or methods outperform compound semiconductors, IQE could be at a disadvantage. |
Posted at 23/10/2024 16:42 by boboty Dishonest lts is doing it again. Who know if Canacord is selling all of it's holding of iqe. We only know they have sold about 1% of the 13% they held and we know because of their rns. Unless lts has other information that he/she can share it is just speculation that canacord selling up. Iqe is a very illiquid share and small volumes of sales or purchases wildly affect the price. Volumes at the moment are between one and five million shares that represents between about 0.1 and 0.5% of the total share capital. The point is don't let the share price be the story - (although painful if you need to sell now) - and act like lemmings - because if there is value you will lose out when real new about stuff other than just share price. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
